Global Lung Cancer Diagnostic And Screening Market Research Report 2025(Status and Outlook)

Report Overview

Lung cancer diagnostic and screening refer to the process of identifying and detecting lung cancer at an early stage through various tests and procedures. This includes imaging tests like X-rays and CT scans, sputum cytology, bronchoscopy, and biopsy. Screening involves identifying individuals at high risk for developing lung cancer, such as smokers, and recommending regular screening tests to detect any abnormalities in the lungs. The ultimate goal of lung cancer diagnostic and screening is to improve patient outcomes by diagnosing the disease early when it is more treatable.

The market for lung cancer diagnostic and screening is experiencing significant growth due to several key factors. Firstly, the rising prevalence of lung cancer globally, particularly among smokers and individuals exposed to environmental risk factors, is driving the demand for effective diagnostic tools and screening programs. Additionally, advancements in technology have led to the development of more accurate and efficient diagnostic tests, such as liquid biopsy and molecular profiling, which are contributing to the market expansion. Moreover, increasing awareness about the importance of early detection and screening for lung cancer is encouraging more individuals to undergo regular screenings, further boosting market growth.

At the same time, government initiatives and healthcare policies aimed at promoting cancer screening and early detection are playing a crucial role in driving the market for lung cancer diagnostic and screening. Reimbursement policies for screening tests, collaborations between healthcare providers and diagnostic companies, and research investments in developing innovative screening technologies are all contributing to the market's positive outlook. Overall, the market for lung cancer diagnostic and screening is poised for continued growth as the importance of early detection and personalized treatment strategies gains prominence in the fight against lung cancer.

This report provides a deep insight into the global Lung Cancer Diagnostic And Screening market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Lung Cancer Diagnostic And Screening Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Lung Cancer Diagnostic And Screening market in any manner.

Global Lung Cancer Diagnostic And Screening Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Pfizer

F.Hoffmann-La Roche AG

Bristol-Myers Squibb Company

Thermo Fisher Scientific

AstraZeneca Plc

Abbott Laboratories

Medtronic Plc

Danaher Corporation

Siemens Healthcare GmbH

FUJIFILM Corporation

KoninklijikePhilips N.V.

GE Healthcare Bio Sciences AB

Quest Diagnostics lIncorporated

Agilent Technologies lnc

Qiagen Inc.

Myriad Genetic Laboratories Inc.

NeoGenomics Laboratories Inc

Canon MedicalSystems Corporation

Eon Health Inc

Market Segmentation (by Type)

Instrument

Consumables and Accessories

Market Segmentation (by Application)

Hospital

Independent Diagnostic Laboratory

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Lung Cancer Diagnostic And Screening Market

Overview of the regional outlook of the Lung Cancer Diagnostic And Screening Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Diagnostic And Screening Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Lung Cancer Diagnostic And Screening
1.2 Key Market Segments
1.2.1 Lung Cancer Diagnostic And Screening Segment by Type
1.2.2 Lung Cancer Diagnostic And Screening Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Lung Cancer Diagnostic And Screening Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Lung Cancer Diagnostic And Screening Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Lung Cancer Diagnostic And Screening Product Life Cycle
3.3 Global Lung Cancer Diagnostic And Screening Revenue Market Share by Company (2020-2025)
3.4 Lung Cancer Diagnostic And Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Lung Cancer Diagnostic And Screening Company Headquarters, Area Served, Product Type
3.6 Lung Cancer Diagnostic And Screening Market Competitive Situation and Trends
3.6.1 Lung Cancer Diagnostic And Screening Market Concentration Rate
3.6.2 Global 5 and 10 Largest Lung Cancer Diagnostic And Screening Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Lung Cancer Diagnostic And Screening Value Chain Analysis
4.1 Lung Cancer Diagnostic And Screening Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Lung Cancer Diagnostic And Screening Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 PEST Analysis
5.6.1 Industry Policies Analysis
5.6.2 Economic Environment Analysis
5.6.3 Social Environment Analysis
5.6.4 Technological Environment Analysis
5.7 Global Lung Cancer Diagnostic And Screening Market Porter's Five Forces Analysis
6 Lung Cancer Diagnostic And Screening Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Diagnostic And Screening Market Size Market Share by Type (2020-2025)
6.3 Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Type (2021-2025)
7 Lung Cancer Diagnostic And Screening Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Diagnostic And Screening Market Size (M USD) by Application (2020-2025)
7.3 Global Lung Cancer Diagnostic And Screening Sales Growth Rate by Application (2020-2025)
8 Lung Cancer Diagnostic And Screening Market Segmentation by Region
8.1 Global Lung Cancer Diagnostic And Screening Market Size by Region
8.1.1 Global Lung Cancer Diagnostic And Screening Market Size by Region
8.1.2 Global Lung Cancer Diagnostic And Screening Market Size Market Share by Region
8.2 North America
8.2.1 North America Lung Cancer Diagnostic And Screening Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Lung Cancer Diagnostic And Screening Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Lung Cancer Diagnostic And Screening Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Lung Cancer Diagnostic And Screening Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Lung Cancer Diagnostic And Screening Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Pfizer
9.1.1 Pfizer Basic Information
9.1.2 Pfizer Lung Cancer Diagnostic And Screening Product Overview
9.1.3 Pfizer Lung Cancer Diagnostic And Screening Product Market Performance
9.1.4 Pfizer Lung Cancer Diagnostic And Screening SWOT Analysis
9.1.5 Pfizer Business Overview
9.1.6 Pfizer Recent Developments
9.2 F.Hoffmann-La Roche AG
9.2.1 F.Hoffmann-La Roche AG Basic Information
9.2.2 F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Product Overview
9.2.3 F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Product Market Performance
9.2.4 F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening SWOT Analysis
9.2.5 F.Hoffmann-La Roche AG Business Overview
9.2.6 F.Hoffmann-La Roche AG Recent Developments
9.3 Bristol-Myers Squibb Company
9.3.1 Bristol-Myers Squibb Company Basic Information
9.3.2 Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Product Overview
9.3.3 Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Product Market Performance
9.3.4 Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening SWOT Analysis
9.3.5 Bristol-Myers Squibb Company Business Overview
9.3.6 Bristol-Myers Squibb Company Recent Developments
9.4 Thermo Fisher Scientific
9.4.1 Thermo Fisher Scientific Basic Information
9.4.2 Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Product Overview
9.4.3 Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Product Market Performance
9.4.4 Thermo Fisher Scientific Business Overview
9.4.5 Thermo Fisher Scientific Recent Developments
9.5 AstraZeneca Plc
9.5.1 AstraZeneca Plc Basic Information
9.5.2 AstraZeneca Plc Lung Cancer Diagnostic And Screening Product Overview
9.5.3 AstraZeneca Plc Lung Cancer Diagnostic And Screening Product Market Performance
9.5.4 AstraZeneca Plc Business Overview
9.5.5 AstraZeneca Plc Recent Developments
9.6 Abbott Laboratories
9.6.1 Abbott Laboratories Basic Information
9.6.2 Abbott Laboratories Lung Cancer Diagnostic And Screening Product Overview
9.6.3 Abbott Laboratories Lung Cancer Diagnostic And Screening Product Market Performance
9.6.4 Abbott Laboratories Business Overview
9.6.5 Abbott Laboratories Recent Developments
9.7 Medtronic Plc
9.7.1 Medtronic Plc Basic Information
9.7.2 Medtronic Plc Lung Cancer Diagnostic And Screening Product Overview
9.7.3 Medtronic Plc Lung Cancer Diagnostic And Screening Product Market Performance
9.7.4 Medtronic Plc Business Overview
9.7.5 Medtronic Plc Recent Developments
9.8 Danaher Corporation
9.8.1 Danaher Corporation Basic Information
9.8.2 Danaher Corporation Lung Cancer Diagnostic And Screening Product Overview
9.8.3 Danaher Corporation Lung Cancer Diagnostic And Screening Product Market Performance
9.8.4 Danaher Corporation Business Overview
9.8.5 Danaher Corporation Recent Developments
9.9 Siemens Healthcare GmbH
9.9.1 Siemens Healthcare GmbH Basic Information
9.9.2 Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Product Overview
9.9.3 Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Product Market Performance
9.9.4 Siemens Healthcare GmbH Business Overview
9.9.5 Siemens Healthcare GmbH Recent Developments
9.10 FUJIFILM Corporation
9.10.1 FUJIFILM Corporation Basic Information
9.10.2 FUJIFILM Corporation Lung Cancer Diagnostic And Screening Product Overview
9.10.3 FUJIFILM Corporation Lung Cancer Diagnostic And Screening Product Market Performance
9.10.4 FUJIFILM Corporation Business Overview
9.10.5 FUJIFILM Corporation Recent Developments
9.11 KoninklijikePhilips N.V.
9.11.1 KoninklijikePhilips N.V. Basic Information
9.11.2 KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Product Overview
9.11.3 KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Product Market Performance
9.11.4 KoninklijikePhilips N.V. Business Overview
9.11.5 KoninklijikePhilips N.V. Recent Developments
9.12 GE Healthcare Bio Sciences AB
9.12.1 GE Healthcare Bio Sciences AB Basic Information
9.12.2 GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Product Overview
9.12.3 GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Product Market Performance
9.12.4 GE Healthcare Bio Sciences AB Business Overview
9.12.5 GE Healthcare Bio Sciences AB Recent Developments
9.13 Quest Diagnostics lIncorporated
9.13.1 Quest Diagnostics lIncorporated Basic Information
9.13.2 Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Product Overview
9.13.3 Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Product Market Performance
9.13.4 Quest Diagnostics lIncorporated Business Overview
9.13.5 Quest Diagnostics lIncorporated Recent Developments
9.14 Agilent Technologies lnc
9.14.1 Agilent Technologies lnc Basic Information
9.14.2 Agilent Technologies lnc Lung Cancer Diagnostic And Screening Product Overview
9.14.3 Agilent Technologies lnc Lung Cancer Diagnostic And Screening Product Market Performance
9.14.4 Agilent Technologies lnc Business Overview
9.14.5 Agilent Technologies lnc Recent Developments
9.15 Qiagen Inc.
9.15.1 Qiagen Inc. Basic Information
9.15.2 Qiagen Inc. Lung Cancer Diagnostic And Screening Product Overview
9.15.3 Qiagen Inc. Lung Cancer Diagnostic And Screening Product Market Performance
9.15.4 Qiagen Inc. Business Overview
9.15.5 Qiagen Inc. Recent Developments
9.16 Myriad Genetic Laboratories Inc.
9.16.1 Myriad Genetic Laboratories Inc. Basic Information
9.16.2 Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Product Overview
9.16.3 Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Product Market Performance
9.16.4 Myriad Genetic Laboratories Inc. Business Overview
9.16.5 Myriad Genetic Laboratories Inc. Recent Developments
9.17 NeoGenomics Laboratories Inc
9.17.1 NeoGenomics Laboratories Inc Basic Information
9.17.2 NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Product Overview
9.17.3 NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Product Market Performance
9.17.4 NeoGenomics Laboratories Inc Business Overview
9.17.5 NeoGenomics Laboratories Inc Recent Developments
9.18 Canon MedicalSystems Corporation
9.18.1 Canon MedicalSystems Corporation Basic Information
9.18.2 Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Product Overview
9.18.3 Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Product Market Performance
9.18.4 Canon MedicalSystems Corporation Business Overview
9.18.5 Canon MedicalSystems Corporation Recent Developments
9.19 Eon Health Inc
9.19.1 Eon Health Inc Basic Information
9.19.2 Eon Health Inc Lung Cancer Diagnostic And Screening Product Overview
9.19.3 Eon Health Inc Lung Cancer Diagnostic And Screening Product Market Performance
9.19.4 Eon Health Inc Business Overview
9.19.5 Eon Health Inc Recent Developments
10 Lung Cancer Diagnostic And Screening Market Forecast by Region
10.1 Global Lung Cancer Diagnostic And Screening Market Size Forecast
10.2 Global Lung Cancer Diagnostic And Screening Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Lung Cancer Diagnostic And Screening Market Size Forecast by Country
10.2.3 Asia Pacific Lung Cancer Diagnostic And Screening Market Size Forecast by Region
10.2.4 South America Lung Cancer Diagnostic And Screening Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Lung Cancer Diagnostic And Screening by Country
11 Forecast Market by Type and by Application (2026-2033)
11.1 Global Lung Cancer Diagnostic And Screening Market Forecast by Type (2026-2033)
11.2 Global Lung Cancer Diagnostic And Screening Market Forecast by Application (2026-2033)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings